Catalyst Wire Dossier Catalyst Wire Dossier
EMA guidance · 2022-08-19

EMA’s Emergency Task Force advises on intradermal use of Imvanex / Jynneos against monkeypox

View source ↗

Summary

EMA’s Emergency Task Force recommends intradermal administration of Imvanex/Jynneos for monkeypox to optimize dose use and supply during outbreaks.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Imvanex (Modified vaccinia Ankara (MVA-BN) vaccine)
  • JYNNEOS (Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN))